Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with higher rates of hemolysis have lower steady-state Hb levels and are more likely to develop vascular injury and organ dysfunction as they age, manifesting as pulmonary hypertension, diastolic left heart disease, and renal dysfunction (proteinuria, albuminuria, and chronic kidney dysfunction) (62, 64, 65, 70, 79).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [64]
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationQuiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Cited by
Items 801–900 of 999
Starlard‐Davenport, A., Palani, C. D., Zhu, X., & Pace, B. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094192 · Cited by 10
Pulmonary Hypertension, Tricuspid Regurgitant Velocity Screening, and the Nitric Oxide Pathway
Hassell, K. L. (2011) · Hematology · doi:10.1182/asheducation-2011.1.419 · Cited by 10
The enigma of pulmonary hypertension after splenectomy--does the megakaryocyte provide a clue?
Thachil, J. V. (2009) · QJM · doi:10.1093/qjmed/hcp092 · Cited by 9
Lamina, M. O., Animasahun, B. A., Diaku-Akinwumi, I., & Njokanma, O. F. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.04.02 · Cited by 9
Echocardiographic evaluation of thalassemia intermedia patients in Duhok, Iraq
Mohammad, A. M. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-183 · Cited by 10
Morris, C. R. (2010) · The Open Nitric Oxide Journal · doi:10.2174/1875042701002020041 · Cited by 10
Lionnet, F., Stankovic, K., & Girot, R. (2009) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(09)49949-7 · Cited by 13
Calpain-1 regulates platelet function in a humanized mouse model of sickle cell disease
Nwankwo, J. O., Gremmel, T., Gerrits, A. J., Mithila, F. J., Warburton, R. R., Hill, N. S., Lu, Y., Richey, L. J., Jakubowski, J. A., Frelinger, A. L., et al. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.10.018 · Cited by 9
Mechanisms of and obstacles to iron cardiomyopathy in thalassemia
Peng, C., Chang, J.-S., Wu, K.-H., Tsai, C.-H., & Lin, H.-S. (2008) · Frontiers in bioscience · doi:10.2741/3130 · Cited by 9
Lucero, M. J., Lisk, C., Cendali, F. I., Swindle, D. C., Setua, S., Thangaraju, K., Pak, D. I., O’Boyle, Q., Lu, S., Tolson, R., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.01.045 · Cited by 9
Prohaska, C. C., Zhang, X., Schwantes-An, T.-H. L., Stearman, R. S., Hooker, S. E., Kittles, R. A., Aldred, M. A., Lutz, K. A., Pauciulo, M. W., Nichols, W. C., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12227 · Cited by 8
d’Humières, T., Bouvarel, A., Boyer, L., Savale, L., Guillet, H., Alassaad, L., Luna, G. D., Berti, E., Iles, S., D'Orengiani, A.-L. P. H. D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61689-w · Cited by 9
Linguraru, M. G., Pura, J. A., Gladwin, M. T., Koroulakis, A. I., Minniti, C. P., Machado, R. F., Kato, G. J., & Wood, B. J. (2014) · Pulmonary Circulation · doi:10.1086/675997 · Cited by 8
Self-citationMaron, B. A., Machado, R. F., & Shimoda, L. A. (2016) · Pulmonary Circulation · doi:10.1086/688315 · Cited by 8
Soh, M. C., Sankaran, S., Chung, N. A. Y., Nelson‐Piercy, C., Howard, J., Robinson, S. E., & Oteng‐Ntim, E. (2016) · Obstetric Medicine · doi:10.1177/1753495x16651529 · Cited by 9
Cardiovascular changes in children with sickle cell crisis
Onalo, R., Cooper, P., Cilliers, A. M., & Nnebe‐Agumadu, U. (2020) · Cardiology in the Young · doi:10.1017/s1047951120000037 · Cited by 8
miRNA profile and disease severity in patients with sickle cell anemia
Biassi, T. P., Guerra‐Shinohara, E. M., Moretti, P. N. S., Dutra, V. D. F., Cabañas‐Pedro, A. C., Mecabô, G., Colleoni, G. W. B., & Figueiredo, M. S. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04665-y · Cited by 8
Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia
Lobo, C. L. D. C., do Nascimento, E. M., Abelha, R. P., Queiroz, A. M. M., Connes, P., Cardoso, G. P., & Ballas, S. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137539 · Cited by 8
Morsy, M. F., Alnajjar, A. A., Almuzainy, I. S., Alhawsawi, Z. M., Alserafi, M. H., & Ahmed, A. A. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4468 · Cited by 8
Pulmonary hypertension in an adult sickle cell population in Guadeloupe
Billy-Brissac, R., Blanchet‐Deverly, A., Etienne‐Julan, M., & Foucan, L. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.01.015 · Cited by 8
CT and image processing non-invasive indicators of sickle cell secondary pulmonary hypertension
Linguraru, M. G., Orandi, B. J., Uitert, R. L. V., Mukherjee, N., Summers, R. M., Gladwin, M. T., Machado, R. F., & Wood, B. J. (2008) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2008.4649289 · Cited by 8
Self-citationGeard, A. F., Pule, G. D., Chelo, D., Bitoungui, V. J. N., & Wonkam, A. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0125 · Cited by 9
Ferrão, T. D. O., Martins‐Filho, P. R., Aragão, C., Santana, M., Nascimento, A., Cardoso, T. S., & Cipolotti, R. (2017) · Radiologia Brasileira · doi:10.1590/0100-3984.2015.0180 · Cited by 8
Boyd, J. H., Strunk, R. C., & Morgan, W. J. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.04.056 · Cited by 8
Garrett, M. E., Foster, M. W., Telen, M. J., & Ashley‐Koch, A. E. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00748 · Cited by 9
Owusu, S. K., Mapani, M., Visagie, A., Marozva, N., Yassin, A., Vanker, A., Hendricks, M. G., Davidson, A., Ansong, D., Zar, H. J., et al. (2024) · Journal of the Pan African Thoracic Society · doi:10.25259/jpats_30_2023 · Cited by 8
Hersi, K., Ramani, G. V., Law, J. Y., Sadek, A. S., Vaidya, A., Gladwin, M. T., & Cassady, S. J. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12362 · Cited by 7
Self-citationGarcía-Ribas, C., Ble, M., Gómez, M., Mas‐Stachurska, A., Farré, N., & Cladellas, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.720643 · Cited by 7
Brooks, S., Ruhl, A. P., Zeng, X., Cruz, P., Hassan, S. A., Kamenyeva, O., Hakim, M. A., Ridley, L. A., Nagata, B. M., Kabát, J., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.066003 · Cited by 8
Dhabangi, A., Ainomugisha, B., Cserti-Gazdewich, C. M., Ddungu, H., Kyeyune, D., Musisi, E., Opoka, R. O., Stowell, C. P., & Dzik, S. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.01.007 · Cited by 7
Dosunmu-Ogunbi, A. M., Yuan, S. S., Shiwarski, D. J., Tashman, J. W., Reynolds, M. J., Feinberg, A. W., Novelli, E. M., Shiva, S., & Straub, A. C. (2022) · Function · doi:10.1093/function/zqac005 · Cited by 12
Knutsen, R. H., Gober, L. M., Kronquist, E. K., Kaur, M., Donahue, D., Springer, D., Yu, Z., Chen, M. Y., Fu, Y., Choobdar, F., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.886813 · Cited by 7
Pulmonary hypertension screening in children with sickle cell disease
Chan, K. H., Rizvi, S. H., Jesus-Rojas, W. D., Stark, J. M., Mosquera, R. A., Prada-Ruiz, A. C., Gonzales, T. R., Brown, D., Menon, N., Nguyen, T. T., et al. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.29980 · Cited by 8
Clinical and Pathophysiological Aspects of Sickle Cell Anemia
Steinberg, M. H., Ohene‐Frempong, K., & Heeney, M. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.027 · Cited by 9
Diastolic dysfunction in sickle cell
Kato, G. J., & Sachdev, V. (2010) · Blood · doi:10.1182/blood-2010-04-279919 · Cited by 7
Self-citationField, J. J., Madadi, A. R., Siegel, M. J., & Narra, V. R. (2009) · American Journal of Hematology · doi:10.1002/ajh.21491 · Cited by 7
The incidence of anaemia in adult patients with cardiovascular diseases in northwest Iran.
Alizadehasl, A., Golmohammadi, Z., Panjavi, L., Mahmoodmoradi, S., & Azarfarin, R. (2011) · PubMed · Cited by 7
Ribera, M. C. V., Ribera, R. B., Koifman, R. J., & Koifman, S. (2013) · Cardiology in the Young · doi:10.1017/s104795111300156x · Cited by 7
Gladwin, M. T., & Kato, G. J. (2007) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-6.1.23 · Cited by 7
Self-citationIn-hospital Outcomes and Characteristics of Heart Failure in Sickle Cell Disease
Fadiran, O., Balogun, A. F., Ogunti, R., Buhari, O., Lanka, C., Atanda, A. C., Larbi, D. A., & Mehrotra, P. P. (2019) · Cureus · doi:10.7759/cureus.5660 · Cited by 7
SNPing away at sickle cell pathophysiology
Steinberg, M. H. (2008) · Blood · doi:10.1182/blood-2008-01-135392 · Cited by 7
Sickle Cell Disease–associated Pulmonary Hypertension
McLaughlin, V. V., & Channick, R. N. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-478ed · Cited by 7
The Role of Doppler Echocardiography in Pulmonary Artery Hypertension
Paterson, D. I., & Michelakis, E. D. (2011) · CHEST Journal · doi:10.1378/chest.10-2837 · Cited by 7
Late effects of hemopoietic stem cell transplant for sickle cell disease: monitoring and management
Goldenberg, M. C., Lanzkron, S., & Pecker, L. H. (2024) · Expert Review of Hematology · doi:10.1080/17474086.2024.2423368 · Cited by 7
Simon, T., Savale, L., Skaarup, K. G., Breillat, P., Pham, L., Nouraie, M. S., Johansen, N. D., Inamo, J., Lionnet, F., Loko, G., et al. (2025) · American Journal of Hematology · doi:10.1002/ajh.27768 · Cited by 7
Ramadas, N., & Sparkenbaugh, E. (2025) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2025.103193 · Cited by 8
Dhédin, N., Paillard, C., Dalle, J., Ouachée-Chardin, M., Buchbinder, N., Brissot, É., Beguin, Y. P., Masouridi‐Levrat, S., Yakoub‐Agha, I., Bernit, E., et al. (2020) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.06.003 · Cited by 7
Galadanci, N. A., Johnson, W. H., Carson, A. P., Hellemann, G. S., Howard, V. J., & Kanter, J. (2022) · Haematologica · doi:10.3324/haematol.2021.280480 · Cited by 8
Njoku, F. U., Zhang, X., Shah, B. N., Han, J., Machado, R. F., Saraf, S. L., & Gordeuk, V. R. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117223 · Cited by 9
Cardiovascular Consequences of Sickle Cell Disease
Bahashwan, S., Almuhanna, R., Hazza, M. A., Baarma, R., AlNajjar, A., Siddiqui, F., Fatani, S., Barefah, A., Alahwal, H. M., Almohammadi, A. T., et al. (2024) · Journal of Blood Medicine · doi:10.2147/jbm.s455564 · Cited by 8
Gene Therapies for Sickle Cell Disease
Weaver, S. B., Singh, D., & Wilson, K. M. (2024) · Journal of Pharmacy Technology · doi:10.1177/87551225241268742 · Cited by 6
Mehari, A., Thomas, A. V., Thomas, A. N., & Johnson, M. S. (2016) · Ethnicity & Disease · doi:10.18865/ed.26.4.545 · Cited by 8
Lilje, C., Harry, J., Gajewski, K. K., & Gardner, R. V. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26606 · Cited by 6
Huston, J., Frantz, R. P., & Brittain, E. L. (2019) · Pulmonary Circulation · doi:10.1177/2045894019844994 · Cited by 6
Red-Colored Urine in the Cardiac Surgical Patient—Diagnosis, Causes, and Management
Koh, L. Y., & Hwang, N. C. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.10.014 · Cited by 6
Johnson, M. C., Johnikin, M. J., Euteneuer, J. C., DeBaun, M. R., & Hildebolt, C. F. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25239 · Cited by 6
Clasificación actual de la hipertensión pulmonar
Naval, N. (2011) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 6
Huang, J., Lin, T., Li, Z., Xu, R., Huang, H., & Jiang, W. (2010) · American Journal of Hematology · doi:10.1002/ajh.21720 · Cited by 7
Hypertension artérielle pulmonaire et drépanocytose
Savale, L., Maître, B., Bachir, D., Galactéros, F., Simonneau, G., & Parent, F. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.04.021 · Cited by 6
Electrolyte profile and prevalent causes of sickle cell crisis in Enugu, Nigeria
Ibe, E. O., Ezeoke, A. C. J., Emeodi, I., Akubugwo, E. I., Elekwa, E., Ugonabo, M. C., & Ugbajah, W. C. (2009) · African Journal of Biochemistry Research · doi:10.5897/ajbr.9000114 · Cited by 6
Grünberg, K., & Mooi, W. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139018760.021 · Cited by 6
Toya, T., Nagatomo, Y., Kagami, K., Yukino, M., Yasuda, R., Namba, T., Ido, Y., Kobayashi, S., Masaki, N., Yada, H., et al. (2019) · International journal of cardiac imaging · doi:10.1007/s10554-019-01548-2 · Cited by 8
Ofori-Acquah, S. F. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30348-x · Cited by 6
Firth, P. G., & Haver, K. E. (2009) · Elsevier eBooks · doi:10.1016/b978-141603134-5.50015-9 · Cited by 6
Anemia at Altitude: Thalassemia, Sickle Cell Disease, and Other Inherited Anemias
DeLoughery, T. G. (2021) · High Altitude Medicine & Biology · doi:10.1089/ham.2021.0038 · Cited by 8
Troponin Elevation in Sickle Cell Disease
Akkuş, N. İ., Rajpal, S., Hilbun, J., Dwary, A. D., Smith, T. R., Mina, G. S., & Reddy, P. C. (2021) · Medical Principles and Practice · doi:10.1159/000517540 · Cited by 7
Ezenwa, M. O., Yao, Y., Mandernach, M. W., Fedele, D. A., Lucero, R. J., Corless, I. B., Dyal, B. W., Belkin, M. H., Rohatgi, A., & Wilkie, D. J. (2022) · JMIR Research Protocols · doi:10.2196/33818 · Cited by 8
Walter, P. B., Hohman, L. S., Rokeby, A., Lum, J. J., Hagar, R. W., Lavrisha, L., Saulys, A., Kuypers, F. A., Vichinsky, E. P., & Morris, C. R. (2022) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2022.102856 · Cited by 7
Maxwell, L. G., Goodwin, S. R., Mancuso, T. J., Baum, V. C., Zuckerberg, A. L., Morgan, P. G., Motoyama, E. K., Davis, P. J., & Sullivan, K. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06612-9.00036-5 · Cited by 6
Endothelin Receptor Antagonists for the Treatment of Pulmonary Arterial Hypertension
Tapson, V. F., & Barst, R. J. (2010) · Springer eBooks · doi:10.1007/978-0-387-87429-6_105 · Cited by 6
Diagnostic et classification de l’hypertension pulmonaire
Montani, D., & Chaouat, A. (2010) · La Presse Médicale · doi:10.1016/s0755-4982(10)70002-6 · Cited by 6
Prevalence of Pulmonary Arterial Hypertension among Sickle Cell Disease Patients in AL Hassa
Al-Khoufi, E. A. S. (2013) · Global Journal of Health Science · doi:10.5539/gjhs.v5n5p174 · Cited by 9
Hemolytic Anemia Associated Pulmonary Hypertension
Machado, R. F., & Gladwin, M. T. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-2246-6.50018-3 · Cited by 6
Self-citationEchocardiographic abnormalities in Brazilian sickle cell patients
Vicari, P., Cavalheiro, R. D. C. R., de Gouveia, A., Filho, O. C., & Figueiredo, M. S. (2005) · American Journal of Hematology · doi:10.1002/ajh.20238 · Cited by 6
Cho, G., & Hambleton, I. R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008360.pub2 · Cited by 7
Krishnamurti, L. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2019.12.008 · Cited by 5
As a good prognostic sign, Autosplenectomy is higher in females in Sickle Cell Diseases
Helvacı, M. R., Pappel, V., Piral, K., Ozer, S., Camlibel, M., Sencan, H., Davran, R., Abyad, A., & Pocock, L. (2023) · Middle East Journal of Nursing · doi:10.5742/mejn2023.9378042 · Cited by 4
Konté, K., Afzali‐Hashemi, L., Baas, K. P. A., Schrantee, A., Wood, J. C., Nur, E., Nederveen, A. J., & Biemond, B. J. (2024) · American Journal of Hematology · doi:10.1002/ajh.27522 · Cited by 5
Subclinical Cardiac Dysfunction Is Associated With Extracardiac Organ Damages
Menet, A., Ranque, B., Diop, I. B., Kingué, S., N’Guetta, R., Diarra, M., Diallo, D. A., Diop, S., Diagne, I., Sanogo, I., et al. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00323 · Cited by 5
Pulmonary hypertension and right ventricular function in Nigerian children with sickle cell anaemia
Peter, I. D., Asani, M. O., Abdullahi, S. U., Aliyu, I., Obaro, S., & Bode-Thomas, F. (2019) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trz038 · Cited by 5
Prognostic significance of plasma bilirubin in sickle cell diseases
Helvacı, M. R., Yalçın, A., Arslanoğlu, Z., Duru, M., Abyad, A., & Pocock, L. (2020) · Middle East Journal of Internal Medicine · doi:10.5742/mejim2020.93792 · Cited by 5
Shah, N. C., & Krishnamurti, L. (2021) · Hematology · doi:10.1182/hematology.2021000322 · Cited by 4
Anesthetic management of a patient with sickle β + thalassemia
Bharati, S., Das, S., Majee, P., & Mandal, S. (2011) · Saudi Journal of Anaesthesia · doi:10.4103/1658-354x.76496 · Cited by 5
Pathophysiology and physical activity in patients with sickle cell anemia
Waltz, X., & Connes, P. (2014) · Movement & Sport Sciences - Science & Motricité · doi:10.1051/sm/2013105 · Cited by 8
Does hydroxyurea prevent pulmonary complications of sickle cell disease?
Buckner, T. W., & Ataga, K. I. (2014) · Hematology · doi:10.1182/asheducation-2014.1.432 · Cited by 6
Inflammatory Biomarkers and Cardiovascular Complications in Sickle Cell Disease: A Review
Jacobs, A. S., Ayinde, H. O., & Lee, D. L. (2013) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-013-0325-x · Cited by 5
Nathan, D. G. (2011) · Blood · doi:10.1182/blood-2011-08-370338 · Cited by 5
Sex Hormones and Vascular Protection in Pulmonary Arterial Hypertension
Christou, H. A., & Khalil, R. A. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181fa8e20 · Cited by 6
Tidake, A., Gangurde, P., Taksande, A. R., Mahajan, A. U., & Nathani, P. (2014) · Cardiology in the Young · doi:10.1017/s1047951114002455 · Cited by 5
Sudden unexpected death in an undiagnosed sickle disease
Pillai, L. V., Husainy, S., Gosavi, S., & Vaidya, N. V. (2005) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.17096 · Cited by 5
Orphan drugs for sickle vaso-occlusion: dawn of a new era of targeted treatment
Dampier, C. (2015) · Orphan Drugs Research and Reviews · doi:10.2147/odrr.s46305 · Cited by 5
Vargas, P. E., & López‐Candales, A. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2016.1115715 · Cited by 5
Medoff, B. D., Shepard, J.-A. O., Smith, R. N., & Kratz, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmcpc059012 · Cited by 5
Guía de práctica clínica para el diagnóstico y tratamiento de la hipertensión pulmonar
Galiè, N., Hoeper, M. M., Humbert, M. J. C., Torbicki, A., Vachiéry, J., Barberà, J. A., Beghetti, M., Corris, P. A., Gaine, S., Gibbs, J. S. R., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73539-x · Cited by 8
Arginine Metabolism, Pulmonary Hypertension, and Sickle Cell Disease—Reply
Morris, C. R., Vichinsky, E. P., Kato, G. J., Gladwin, M. T., Hazen, S. L., & Morris, S. M. (2005) · JAMA · doi:10.1001/jama.294.19.2433-b · Cited by 5
Self-citationDoppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq
Al-Allawi, N. A. S., Mohammad, A. M., & Zebari, S. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162036 · Cited by 6
Validation of a composite vascular high‐risk profile for adult patients with sickle cell disease
Nouraie, M. S., Little, J. A., Hildesheim, M. E., Gibbs, J. S. R., Morris, C. R., Machado, R. F., Kato, G. J., Gordeuk, V. R., & Gladwin, M. T. (2019) · American Journal of Hematology · doi:10.1002/ajh.25624 · Cited by 5
Self-citationCultural Competence in Nurses in Saudi Arabia: A Systematic Review
Aboshaiqah, A. E. (2023) · Middle East Journal of Nursing · doi:10.5742/mejn2023.9378040 · Cited by 11
Dabirian, M., Janbabaei, G., Karami, H., Nabati, M., Aarabi, M., Namazi, M., & Darvishi‐Khezri, H. (2017) · Acta Informatica Medica · doi:10.5455/aim.2017.25.9-13 · Cited by 7
Genetic Modulation of Sickle Cell Disease and Thalassemia
Steinberg, M. H., & Nagel, R. L. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.037 · Cited by 5
Metadata
- Authors
- Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 886-895
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148547093
- Cited by
- 1,325
- References
- 42
- Citations by year
- 2026: 42 · 2025: 30 · 2024: 45 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 34 · 2019: 61 · 2018: 43 · 2017: 57 · 2016: 74 · 2015: 64 · 2014: 76 · 2013: 64 · 2012: 68
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary hypertension, sickle cell disease, mortality risk, tricuspid regurgitation velocity, Doppler echocardiography, chronic hemolysis, hydroxyurea therapy, risk factors, alkaline phosphatase, lactate dehydrogenase, transferrin, cardiovascular complications, renal complications
- MeSH terms
- Adult, Anemia, Sickle Cell, Antisickling Agents, Blood Pressure, Cause of Death, Drug Resistance, Female, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Male, Pulmonary Artery, Risk Factors, Tricuspid Valve Insufficiency, Echocardiography, Doppler, Prevalence, Survival Rate, Logistic Models, Ventricular Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.